BRCA1/2 mutation prevalence in triple-negative breast cancer patients without family history of breast and ovarian cancer.

被引：3
|
作者：
Rhiem, Kerstin
Engel, Christoph
Engel, Jutta
Niederacher, Dieter
Sutter, Christian
Varon-Mateeva, Raymonda
Steinemann, Doris
Arnold, Norbert
Dworniczak, Bernd
Wang-Gohrke, Shan
Gehrig, Andrea
Wappenschmidt, Barbara
Meindl, Alfons
Schmutzler, Rita K.
机构：
[1] Univ Hosp Cologne, Fac Med, Ctr Hereditary Breast & Ovarian Canc, Ctr Integrated Oncol CIO, Cologne, Germany
[2] Ctr Mol Med Cologne CMMC, Cologne, Germany
[3] Univ Cologne, Cologne, Germany
[4] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany
[5] LMU Munchen, Inst Med Informat Biostat & Epidemiol, Munich, Germany
[6] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Obstet & Gynaecol, Dusseldorf, Germany
[7] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany
[8] Charite, Campus Virchov Klinikum, Inst Human Genet, Berlin, Germany
[9] Hannover Med Sch, Inst Cell & Mol Pathol, Hannover, Germany
[10] Univ Kiel, Kiel, Germany
[11] Univ Munster, Inst Human Genet, Munster, Germany
[12] Univ Hosp Ulm, Dept Obstet & Gynaecol, Ulm, Germany
[13] Univ Wurzburg, Inst Human Genet, Dept Med Genet, Ctr Familial Breast & Ovarian Canc 11, Wurzburg, Germany
[14] Tech Univ Munich, Div Tumor Genet, Dept Obstet & Gynecol, Munich, Germany
[15] Univ Cologne, Fac Med, Ctr Mol Med Cologne CMMC, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1090
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prevalence of germline BRCA1 and BRCA2 mutations in triple-negative breast cancer patients unselected for family history
    Scott, R. J.
    Wong-Brown, M.
    Meldrum, C. J.
    Avery-Kiejda, K.
    [J]. CANCER RESEARCH, 2013, 73
  • [2] Evaluation of BRCA1/2 mutation prevalence in Korean women with triple-negative breast cancer
    Lee, A. S.
    Kang, E. Y.
    Baek, H.
    Chae, S.
    Kim, E-K.
    Kim, S. W.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 16 - 16
  • [3] Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer
    Maksimenko, Jelena
    Irmejs, Arvids
    Nakazawa-Miklasevica, Miki
    Melbarde-Gorkusa, Inga
    Trofimovics, Genadijs
    Gardovskis, Janis
    Miklasevics, Edvins
    [J]. ONCOLOGY LETTERS, 2014, 7 (01) : 278 - 284
  • [4] Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer.
    Muendlein, Axel
    Rhode, Bettina
    Gasser, Klaus
    Kinz, Elena
    Drexel, Heinz
    Hofmann, Wera
    Schindler, Verena
    Kapoor, Rita
    Decker, Thomas
    Lang, Alois
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [6] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Michelle W. Wong-Brown
    Cliff J. Meldrum
    Jane E. Carpenter
    Christine L. Clarke
    Steven A. Narod
    Anna Jakubowska
    Helena Rudnicka
    Jan Lubinski
    Rodney J. Scott
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
  • [7] Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
    Christoph Engel
    Kerstin Rhiem
    Eric Hahnen
    Sibylle Loibl
    Karsten E. Weber
    Sabine Seiler
    Silke Zachariae
    Jan Hauke
    Barbara Wappenschmidt
    Anke Waha
    Britta Blümcke
    Marion Kiechle
    Alfons Meindl
    Dieter Niederacher
    Claus R. Bartram
    Dorothee Speiser
    Brigitte Schlegelberger
    Norbert Arnold
    Peter Wieacker
    Elena Leinert
    Andrea Gehrig
    Susanne Briest
    Karin Kast
    Olaf Riess
    Günter Emons
    Bernhard H. F. Weber
    Jutta Engel
    Rita K. Schmutzler
    [J]. BMC Cancer, 18
  • [8] Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
    Engel, Christoph
    Rhiem, Kerstin
    Hahnen, Eric
    Loibl, Sibylle
    Weber, Karsten E.
    Seiler, Sabine
    Zachariae, Silke
    Hauke, Jan
    Wappenschmidt, Barbara
    Waha, Anke
    Bluemcke, Britta
    Kiechle, Marion
    Meindl, Alfons
    Niederacher, Dieter
    Bartram, Claus R.
    Speiser, Dorothee
    Schlegelberger, Brigitte
    Arnold, Norbert
    Wieacker, Peter
    Leinert, Elena
    Gehrig, Andrea
    Briest, Susanne
    Kast, Karin
    Riess, Olaf
    Emons, Guenter
    Weber, Bernhard H. F.
    Engel, Jutta
    Schmutzler, Rita K.
    [J]. BMC CANCER, 2018, 18
  • [9] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [10] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    [J]. LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
12345